US 8314217
Cross-linked glycopeptide-cephalosporin antibiotics
granted A61KA61K38/00A61P
Quick answer
US patent 8314217 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P31/04